No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Analgesia / standards
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Biomarkers / blood
-
Calcium Channel Blockers / therapeutic use
-
Cardiology / standards*
-
Coronary Angiography / standards
-
Electrocardiography
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Inflammation / metabolism
-
Myocardial Infarction / diagnosis*
-
Myocardial Infarction / metabolism
-
Myocardial Infarction / therapy*
-
Myocardial Revascularization / standards
-
Natriuretic Peptides / metabolism
-
New Zealand
-
Platelet Aggregation Inhibitors / therapeutic use
-
Risk Assessment / methods
-
Troponin / blood
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Biomarkers
-
Calcium Channel Blockers
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Natriuretic Peptides
-
Platelet Aggregation Inhibitors
-
Troponin